CaRe Clinic Joins hyperCORE International Network to Enhance Global Clinical Research Capabilities
TL;DR
Joining hyperCORE International gives CaRe Clinic a competitive advantage in expanding global reach and capabilities through alliance partnerships.
CaRe Clinic's community-centric recruitment strategy, state-of-the-art research centers, and strong partnerships contribute to its success in redefining medical research in Canada.
CaRe Clinic's partnership with hyperCORE International aims to pioneer breakthroughs that will benefit patients worldwide, highlighting Canada's robust clinical research ecosystem on the global stage.
CaRe Clinic's broad combination of investigators' patient databases and access to a reservoir of over 1.8 million potential patients makes it a key player in advancing clinical research.
Found this article helpful?
Share it with your network and spread the knowledge!
CaRe Clinic, a prominent multi-specialty research organization based in Alberta, Canada, has joined the collaborative super network of hyperCORE International, marking a significant expansion of global clinical trial capabilities. This strategic alliance brings together CaRe Clinic's two state-of-the-art research centers serving Calgary and Red Deer with hyperCORE's extensive international network, creating new opportunities for clinical research advancement across multiple therapeutic areas.
The partnership leverages CaRe Clinic's extensive patient database, which provides access to over 1.8 million potential participants through investigators' databases and strong partnerships with affiliated clinics. This vast resource, combined with the organization's community-centric recruitment strategy, offers unparalleled participant recruitment capabilities across various medical indications including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments. Troy Hamilton, Director of Operations at CaRe Clinic, emphasized that this partnership opens doors for unprecedented collaboration and sharing of best practices across borders, which is crucial for clinical research advancement.
hyperCORE International, already an industry leader in providing Phase I-IV clinical trial services, now expands its Canadian presence with multiple locations and multi-therapeutic offerings. The organization's global footprint now spans two continents and five countries with more than 120 active research sites. Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the new partnership, noting it immediately increases hyperCORE's footprint at multiple locations in Canada with multi-therapeutic offerings.
The collaboration combines hyperCORE's decades of clinical research experience, with alliance partners having completed more than 7,000 studies and evaluated thousands of new drugs and treatments in over 150,000 randomized patients, with CaRe Clinic's robust patient recruitment capabilities. This integration is expected to accelerate clinical research and drug development, potentially leading to faster medical breakthroughs across various therapeutic areas while addressing critical challenges in clinical trials such as patient recruitment and retention.
For the broader medical and pharmaceutical industries, this partnership represents a trend toward more integrated, efficient, and globally connected clinical research networks. It underscores the importance of international cooperation in advancing medical science and bringing new treatments to patients worldwide more rapidly and effectively. As the clinical research landscape continues to evolve, such collaborations are likely to play a crucial role in shaping the future of medical research and drug development, ultimately benefiting patients and healthcare systems globally through enhanced research capabilities and accelerated treatment development.
Curated from 24-7 Press Release
